Error: Could not add to watchlist. X

Erste Sparinvest - ESPA Stock Pharma

+ Watchlist
PHARMHA:AV
Acquired
PHARMHA:AV was acquired by EBS:AV
HUF
Fund Type
Open-End Fund
Fund Type
Open-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on -)
-
Total Assets (m EUR) (on 11/13/2014)
31.318
Inception Date
04/24/2008
Last Dividend (on 11/11/2014)
-
Dividend Indicated Gross Yield
-
Fund Managers
-
Front Load Fee
4.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
2.16%
Expense Ratio
-
Top Fund Holdings
Name Position Value % of Fund
Celgene Corp 29.50 k 2.50 m 7.63
Gilead Sciences Inc 25.20 k 2.28 m 6.97
Amgen Inc 17.20 k 2.20 m 6.73
Biogen Inc 8.05 k 2.05 m 6.25
Regeneron Pharmaceuticals Inc 6.50 k 2.02 m 6.18
Vertex Pharmaceuticals Inc 14.45 k 1.27 m 3.88
Alexion Pharmaceuticals Inc 7.95 k 1.22 m 3.71
Illumina Inc 7.45 k 1.14 m 3.49
BioMarin Pharmaceutical Inc 12.90 k 841.77 k 2.57
Mylan NV 19.30 k 800.81 k 2.45
Profile
ESPA Stock Pharma is an open-end investment fund incorporated in Austria. The Fund's objective is income and growth through worldwide investments in pharmaceutical stocks.
ADDRESS
Erste Sparinvest KAG
Habsburgergasse 1a
1010 Vienna
Austria
PHONE
+43 (0) 50100-0